Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Details : COPIKTRA (duvelisib) is an oral inhibitor of phosphoinositide 3-kinase (PI3K), and the first US approved dual inhibitor of PI3K-delta and PI3K-gamma, two enzymes known to help support the growth and survival of malignant cells.
Brand Name : Copiktra
Molecule Type : Small molecule
Upfront Cash : Not Applicable
January 09, 2023
Details : COPIKTRA is an oral dual inhibitor of the PI3K-delta and gamma pathways, which are involved in the proliferation, growth, and migration of malignant cells and are thought to play a role in the formation and maintenance of a supportive tumor microenvironm...
Brand Name : Copiktra
Molecule Type : Small molecule
Upfront Cash : Not Applicable
April 01, 2021
LOOKING FOR A SUPPLIER?